Medical Health & Life Science Research News

Learn details of the organs-on-chips market worth 45.6 million USD by 2022

Medical Market Research

117 Pages Report] Organs-on-chips Market categories the Global market by Application (Physiological model, Toxicity testing), Type (Heart, Intestines, Gut, Liver, Kidney, Lung), Offering (Service, Product), End User (Research Institute, Pharma companies, Academic) & Geography

- Advertising -

Browse 68 market data Tables and 27 Figures spread through 117 Pages and in-depth TOC on "Organs-on-chips Market"

www.marketsandmarkets.com/Market-R…m_campaign=PaidPR

Early buyers will receive 10% customization on this report 

The liver-on-a-chip segment is expected to dominate the market in 2017 

Based on type, the Organs-on-chips Market is segmented into liver, lung, heart, kidney, and other organs-on-chips. In 2017, the accessories segment is expected to account for the largest share of the Organs-on-chips Market.

The large share of this segment can be attributed to the simplicity of this model and the ability of on-chip hepatic tissues to maintain metabolic activity and phenotype similar to the in vivo environment.

Enquiry Report: www.marketsandmarkets.com/Enquiry_…m_campaign=PaidPR

The drug discovery segment is expected to register the highest CAGR during the forecast period. 

- Advertising -

Based on application, the Organs-on-chips Market is segmented into physiological model development, drug discovery, and toxicology research. The drug discovery segment is expected to register the highest CAGR during the forecast period.

The increasing focus on drug discovery, rising need for more predictive in vitro tools for drug development among pharmaceutical companies, and growing preference for alternatives to conventional cell culture and animal models are some of the factors that are driving the growth of the drug discovery segment.

North America to dominate the Organs-on-chips Market 

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as availability of new and advanced organs-on-chips in the market, and favorable government initiatives in terms of funding and programs for basic drug development and research, and the presence of key pharmaceutical companies.

These are regions where the majority of drug development activity is concentrated.

Download PDF Brochurewww.marketsandmarkets.com/pdfdownl…m_campaign=PaidPR

The Organs-on-chips Market is emerging and high growth potential market with the presence of several small players and startups firms. Some of the players in the Organs-on-chips Market include Emulate (US), CN Bio (UK), TissUse (Germany), Mimetas (Netherlands), InSphero (Switzerland), Ascendance Bio (US), Kirkstall (UK), HUREL (HUREL) (US), SynVivo (US), AxoSim (US), and Nortis (US).

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
This email address is being protected from spambots. You need JavaScript enabled to view it.